| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 20, 2023 |
| Accession Number: | 0000950103-22-014035 | |||||
| Submission Type: | POS AM | |||||
|
Attachments
Disclaimer
ADC Therapeutics SA published this content on 20 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 March 2023 10:08:57 UTC.